Improvement of immunogenic chemotherapy by STAT3 inhibition

Heng Yang; Takahiro Yamazaki; Federico Pietrocola; Heng Zhou; Laurence Zitvogel; Yuting Ma; Guido Kroemer

doi:10.1080/2162402X.2015.1078061

Improvement of immunogenic chemotherapy by STAT3 inhibition

Heng Yang, Takahiro Yamazaki, Federico Pietrocola, Heng Zhou, Laurence Zitvogel, Yuting Ma, Guido Kroemer

Résultats de recherche: Contribution à un journal › Article › Revue par des pairs

14 Citations (Scopus)

Résumé

The inhibition of STAT3 may exert cell-autonomous cytotoxic and cytostatic effects, yet may also stimulate anticancer immunosurveillance through the neutralization of immunosuppressive circuitries. In addition, STAT3 inhibition in cancer cells may stimulate the type 1 interferon response elicited by anthracyclines. This pathway results in an enhanced chemotherapy-associated anticancer immune response with improved therapeutic efficacy. Hence, combination therapies that include immunogenic cell death (ICD) inducers and STAT3 inhibitors can be envisaged.

langue originale	Anglais
journal	OncoImmunology
Volume	5
Numéro de publication	2
Les DOIs	https://doi.org/10.1080/2162402X.2015.1078061
état	Publié - 1 févr. 2016

Accès au document

10.1080/2162402X.2015.1078061

Autres fichiers et liens

Lien vers la publication dans Scopus

Contient cette citation

@article{b0a0db284bd740079c8d68135667d99d,

title = "Improvement of immunogenic chemotherapy by STAT3 inhibition",

abstract = "The inhibition of STAT3 may exert cell-autonomous cytotoxic and cytostatic effects, yet may also stimulate anticancer immunosurveillance through the neutralization of immunosuppressive circuitries. In addition, STAT3 inhibition in cancer cells may stimulate the type 1 interferon response elicited by anthracyclines. This pathway results in an enhanced chemotherapy-associated anticancer immune response with improved therapeutic efficacy. Hence, combination therapies that include immunogenic cell death (ICD) inducers and STAT3 inhibitors can be envisaged.",

author = "Heng Yang and Takahiro Yamazaki and Federico Pietrocola and Heng Zhou and Laurence Zitvogel and Yuting Ma and Guido Kroemer",

note = "Publisher Copyright: {\textcopyright} 2016 Taylor & Francis Group, LLC.",

year = "2016",

month = feb,

day = "1",

doi = "10.1080/2162402X.2015.1078061",

language = "English",

volume = "5",

journal = "OncoImmunology",

issn = "2162-4011",

number = "2",

}

TY - JOUR

T1 - Improvement of immunogenic chemotherapy by STAT3 inhibition

AU - Yang, Heng

AU - Yamazaki, Takahiro

AU - Pietrocola, Federico

AU - Zhou, Heng

AU - Zitvogel, Laurence

AU - Ma, Yuting

AU - Kroemer, Guido

PY - 2016/2/1

Y1 - 2016/2/1

N2 - The inhibition of STAT3 may exert cell-autonomous cytotoxic and cytostatic effects, yet may also stimulate anticancer immunosurveillance through the neutralization of immunosuppressive circuitries. In addition, STAT3 inhibition in cancer cells may stimulate the type 1 interferon response elicited by anthracyclines. This pathway results in an enhanced chemotherapy-associated anticancer immune response with improved therapeutic efficacy. Hence, combination therapies that include immunogenic cell death (ICD) inducers and STAT3 inhibitors can be envisaged.

AB - The inhibition of STAT3 may exert cell-autonomous cytotoxic and cytostatic effects, yet may also stimulate anticancer immunosurveillance through the neutralization of immunosuppressive circuitries. In addition, STAT3 inhibition in cancer cells may stimulate the type 1 interferon response elicited by anthracyclines. This pathway results in an enhanced chemotherapy-associated anticancer immune response with improved therapeutic efficacy. Hence, combination therapies that include immunogenic cell death (ICD) inducers and STAT3 inhibitors can be envisaged.

UR - http://www.scopus.com/inward/record.url?scp=84959422812&partnerID=8YFLogxK

U2 - 10.1080/2162402X.2015.1078061

DO - 10.1080/2162402X.2015.1078061

M3 - Article

AN - SCOPUS:84959422812

SN - 2162-4011

VL - 5

JO - OncoImmunology

JF - OncoImmunology

IS - 2

ER -